|
ZSCAN20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.881590E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.739700E-03 |
| Normal-vs-Stage2 |
1.442020E-01 |
| Normal-vs-Stage3 |
5.113800E-02 |
| Normal-vs-Stage4 |
1.292180E-01 |
| Stage1-vs-Stage2 |
5.819200E-01 |
| Stage1-vs-Stage3 |
9.204000E-01 |
| Stage1-vs-Stage4 |
9.893600E-01 |
| Stage2-vs-Stage3 |
6.445000E-01 |
| Stage2-vs-Stage4 |
7.623000E-01 |
| Stage3-vs-Stage4 |
9.528400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.273800E-02 |
| Normal-vs-AfricanAmerican |
5.541700E-03 |
| Normal-vs-Asian |
1.380140E-02 |
| Caucasian-vs-AfricanAmerican |
1.624820E-01 |
| Caucasian-vs-Asian |
2.707900E-02 |
| AfricanAmerican-vs-Asian |
4.378000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.861400E-03 |
| Normal-vs-Female |
6.966400E-01 |
| Male-vs-Female |
2.043100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.566000E-02 |
| Normal-vs-Extreme_Weight |
6.625500E-04 |
| Normal-vs-Obese |
8.645900E-02 |
| Normal-vs-Extreme_Obese |
8.631600E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.093600E-01 |
| Normal_Weight-vs-Obese |
7.459800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.482600E-01 |
| Extreme_Weight-vs-Obese |
6.268200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.860000E-01 |
| Obese-vs-Extreme_Obese |
6.742600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.097600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.290590E-01 |
| Normal-vs-Age(61-80Yrs) |
1.870010E-02 |
| Normal-vs-Age(81-100Yrs) |
5.186700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.819000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.823000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.368500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.618390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.944800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.805700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.336310E-02 |
| Normal-VS-Type2 PRCC |
4.818500E-04 |
| Normal-VS-KIRP CIMP |
2.985600E-01 |
| Normal-VS-Unclassified PRCC |
5.726600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.300000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.655900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.342500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.402600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.981100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.269600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.004830E-04 |
| Normal-vs-N1 |
3.735400E-01 |
| Normal-vs-N2 |
9.844400E-01 |
| N0-vs-N1 |
1.091000E-01 |
| N0-vs-N2 |
4.630200E-01 |
| N1-vs-N2 |
7.040200E-01 |
|
|
